Antifungal susceptibilities of Cryptococcus neoformans

Emerg Infect Dis. 2004 Jan;10(1):143-5. doi: 10.3201/eid1001.020779.


Susceptibility profiles of medically important fungi in less-developed countries remain uncharacterized. We measured the MICs of amphotericin B, 5-flucytosine, fluconazole, itraconazole, and ketoconazole for Cryptococcus neoformans clinical isolates from Thailand, Malawi, and the United States and found no evidence of resistance or MIC profile differences among the countries.

MeSH terms

  • Antifungal Agents / pharmacology*
  • Cryptococcus neoformans / drug effects*
  • Cryptococcus neoformans / isolation & purification
  • Microbial Sensitivity Tests


  • Antifungal Agents